Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4B | 2.3B | 2.5B | 2.7B |
Cost of revenue | 2.1B | 2.2B | 2.2B | 2.5B |
Gross profit | 220M | 132M | 245M | 255M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 132M | 123M | 130M | 132M |
Other operating expenses | -2M | -7M | -1M | -2M |
Operating income | 87M | 13M | 113M | 121M |
Non operating interest income | ||||
Income | 3M | 5M | 4M | 2M |
Expense | 39M | 43M | 40M | 39M |
Other income expense | -15M | -49M | -25M | -17M |
Pretax income | 36M | -74M | 52M | 67M |
Tax provision | 8M | 5M | 43M | 54M |
Net income | 30M | -76M | 11M | 16M |
Basic EPS | — | -0.6 | 0.0 | 0.1 |
Diluted EPS | — | -0.6 | 0.0 | 0.1 |
Basic average shares | — | 145.3M | 145M | 145M |
Diluted average shares | — | 145.3M | 145.1M | 145.1M |
EBITDA | 198M | 115M | 218M | 238M |
Net income from continuing op. | 30M | -76M | 11M | 16M |
Minority interests | -5M | -4M | -7M | 0 |
Preferred stock dividends | — | — | — | — |